We have recently shown that ADAR1 is downregulated along melanoma progression, particularly during the metastatic transition27, thereby enhancing proliferation27 and resistance to tumor-infiltrating lymphocytes32, in an RNA-editing-independent manner. Here, ADAR is linked to melanoma.